Astellas, Roche Diabetes Care team up to integrate Accu-Chek with BlueStar app
Seeking Alpha · 3h ago
J.P. Morgan Remains a Sell on Roche Holding AG (RHHVF)
TipRanks · 4h ago
Tracking John Rogers' Ariel Investments Portfolio - Q4 2022 Update
Seeking Alpha · 9h ago
Astellas, Roche To Develop Integrated Diabetes Self-management Solution With BlueStar
NASDAQ · 11h ago
Health Rounds: Waiting to remove lymph nodes may improve cancer immunotherapy
Reuters · 20h ago
The Zacks Analyst Blog Highlights Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys
NASDAQ · 1d ago
Roche's Slow Growth Shouldn't Drive Investors Away
NASDAQ · 1d ago
Top Stock Reports for Berkshire Hathaway, Roche & Thermo Fisher Scientific
NASDAQ · 1d ago
Unity Biotech sheds 48% after mid-stage setback for wet AMD candidate
Seeking Alpha · 1d ago
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
NASDAQ · 2d ago
Global continuous glucose monitoring market to hit $32B by 2031 – report
Seeking Alpha · 2d ago
FDA draft guidance impacts companies using accelerated approval for oncology drugs
Seeking Alpha · 4d ago
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
NASDAQ · 4d ago
White House seeking alternative supply chains for pharmaceutical ingredients
Seeking Alpha · 5d ago
Health Rounds: Inexpensive diabetes drug cuts long COVID risk
Reuters · 5d ago
Roche (RHHBY) & Lilly to Co-Develop Alzheimer's Detection Device
NASDAQ · 5d ago
Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?
NASDAQ · 6d ago
Novartis, Genentech tout long-term data on muscular atrophy therapies
Seeking Alpha · 6d ago
Roche: A Bitter Pill It Needs To Swallow
Seeking Alpha · 6d ago
Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease
Benzinga · 03/22 11:54
Webull provides a variety of real-time RHHBY stock news. You can receive the latest news about Roche Hldg through multiple platforms. This information may help you make smarter investment decisions.
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.